TABLE 1.

IFI16 expression and survival of ccRCC patients.

Variable	Univariate analysis		Multivariate analysis
	HR (95% CI)	P-value	HR (95% CI)	P-value
Age (≤60 vs. >60 years)	1.546 (1.011–2.362)	0.044	1.632 (1.058–2.520)	0.027
Gender (Female vs. male)	1.013 (0.666–1.541)	0.951	1.040 (0.668–1.618)	0.863
Grade (G1 + G2 vs. G3 + G4)	2.629 (1.655–4.176)	4.26E–05	1.749 (1.066–2.868)	0.027
Stage (I + II vs. III + IV)	3.676 (2.366–5.711)	7.05E–09	1.417 (0.559–3.594)	0.463
T (T1 + T2 vs. T3 + T4)	3.311 (2.167–5.058)	3.07E–08	1.476 (0.642–3.394)	0.359
M (M0 vs. M1)	4.073 (2.634–6.300)	2.76E–10	2.297 (1.358–3.885)	0.002
N (N0 vs. N1)	2.932 (1.516–5.668)	1.00E–03	1.394 (0.686–2.830)	0.358
IFI16 (low vs. high)	1.043 (1.024–1.063)	1.07E–05	1.023 (1.002–1.045)	0.032